Stock profile

FUJIFILM Holdings Corporation(4901.T)

Country: JapanSector: HealthcareIndustry: Medical - DevicesExchange: JPX
P/E TTM
14.3
History
P/E NTM
16.4
Market cap
4.34T
Currency JPY
KvantraRanki71
Value62
Quality76
Momentum79
Current price
3,277.00+2.47%
Benchmarks

No price history available.

Key financial summary

Financials in JPY
2020202120222023202420252026TTM2027E
Total revenue¥m2,315,1412,192,5192,525,7732,859,0412,960,9163,195,8283,356,969N/AN/A
Operating profit¥mLockedLockedLockedLockedLockedLockedLockedLockedLocked
Net profit¥m124,987181,205211,180219,422243,509260,951276,735N/AN/A
EPS reported¥LockedLockedLockedLockedLockedLockedLockedLockedLocked
Operating cashflow per share¥LockedLockedLockedLockedLockedLockedLockedLockedLocked
Capex per share¥LockedLockedLockedLockedLockedLockedLockedLockedLocked
FCF per share¥LockedLockedLockedLockedLockedLockedLockedLockedLocked
Free cash flow¥mLockedLockedLockedLockedLockedLockedLockedLockedLocked
Net debt¥mLockedLockedLockedLockedLockedLockedLockedLockedLocked
Book value equity¥mLockedLockedLockedLockedLockedLockedLockedLockedLocked
Book value per share¥LockedLockedLockedLockedLockedLockedLockedLockedLocked
Number of sharesmLockedLockedLockedLockedLockedLockedLockedLockedLocked
DPS (TTM paid)¥LockedLockedLockedLockedLockedLockedLockedLockedLocked

Financial summary

Financials in JPY
2020202120222023202420252026TTM2027E
Value
P/E LTMxLockedLockedLockedLockedLockedLockedLockedLockedLocked
P/B LTMxLockedLockedLockedLockedLockedLockedLockedLockedLocked
P/S LTMxLockedLockedLockedLockedLockedLockedLockedLockedLocked
P/FCF LTMxLockedLockedLockedLockedLockedLockedLockedLockedLocked
EV/EBITDA LTMxLockedLockedLockedLockedLockedLockedLockedLockedLocked
EV/Sales LTMxLockedLockedLockedLockedLockedLockedLockedLockedLocked
Earnings Yield LTM%LockedLockedLockedLockedLockedLockedLockedLockedLocked
FCF Yield%LockedLockedLockedLockedLockedLockedLockedLockedLocked
Quality
ROE%LockedLockedLockedLockedLockedLockedLockedLockedLocked
ROIC%LockedLockedLockedLockedLockedLockedLockedLockedLocked
Operating margin%LockedLockedLockedLockedLockedLockedLockedLockedLocked
Gross margin%LockedLockedLockedLockedLockedLockedLockedLockedLocked
FCF/Sales%LockedLockedLockedLockedLockedLockedLockedLockedLocked
Growth and momentum
EPS Growth YoY%LockedLockedLockedLockedLockedLockedLockedLockedLocked
Sales Growth YoY%LockedLockedLockedLockedLockedLockedLockedLockedLocked
Net Income Growth YoY%LockedLockedLockedLockedLockedLockedLockedLockedLocked
FCF Growth%LockedLockedLockedLockedLockedLockedLockedLockedLocked
Operating Profit Growth%LockedLockedLockedLockedLockedLockedLockedLockedLocked
Dividend and capital structure
Dividend Yield%LockedLockedLockedLockedLockedLockedLockedLockedLocked
Dividend Growth%LockedLockedLockedLockedLockedLockedLockedLockedLocked
Payout Ratio%LockedLockedLockedLockedLockedLockedLockedLockedLocked
FCF/DebtxLockedLockedLockedLockedLockedLockedLockedLockedLocked
Net Debt/EBITDAxLockedLockedLockedLockedLockedLockedLockedLockedLocked
EBIT/Net interestxLockedLockedLockedLockedLockedLockedLockedLockedLocked
Net debt/market cap%LockedLockedLockedLockedLockedLockedLockedLockedLocked
Net debt/Equity%LockedLockedLockedLockedLockedLockedLockedLockedLocked
Gross debt/equity%LockedLockedLockedLockedLockedLockedLockedLockedLocked

Ratings

Strong Buy
Locked
Buy
Locked
Hold
Locked
Sell
Locked
Strong Sell
Locked
Number of covering analystsLocked

Based on consensus from external analysts. Not Kvantra's opinion.

Company overview

FUJIFILM Holdings Corporation is a global enterprise dedicated to the development, manufacturing, sales, and servicing of an extensive range of solutions, categorized into imaging, healthcare, materials, and business innovation. Its Healthcare division provides a comprehensive suite of products and services designed for prevention, diagnosis, and treatment. These offerings include medical devices, biomedical contract development and manufacturing organization (CDMO) services, pharmaceuticals, regenerative medicine, and cosmetics and dietary supplements. The Materials segment focuses on industrial applications, supplying inkjet digital presses and printing plates for the printing sector, along with industrial inkjet products and print heads. It also offers data storage media and archiving solutions for digital information management, as well as advanced materials for displays, touch panels, semiconductors, image sensors, and functional films. Within the Business Innovation segment, the company delivers office-oriented devices and services, such as digital multifunction machines, printers, software, and cloud-based solutions. It further provides workflow optimization tools for graphical communications companies and offers tailored document services, including system integration and business process outsourcing, to meet diverse business requirements. The Imaging segment covers both traditional photography and advanced optical technologies. It features products like color films, instant cameras, photo developing and printing systems, color papers, and photo printing services. Additionally, this segment produces high-quality optics, including lenses for TV and cinema production, surveillance cameras, industrial inspection, and projectors. Founded in 1934, FUJIFILM Holdings Corporation is headquartered in Tokyo, Japan.

SectorHealthcare
IndustryMedical - Devices
CountryJapan
Trades inJPY

Similar companies

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

FUJIFILM Holdings Corporation (4901.T)

4901.T · JPX · Healthcare
3,277.00+2.47%
Sign up to track this stock

No price history available.

KvantraRank71
P/E TTM14.3
P/E NTM16.4
Market cap4.34T
KvantraRank71 / 100
Value
62
Quality
76
Momentum
79
Financialsin JPY
20242025TTM2026
Ratings
Strong Buy
Locked
Buy
Locked
Hold
Locked
Sell
Locked
Strong Sell
Locked

Based on consensus from external analysts. Not Kvantra's opinion.

About

FUJIFILM Holdings Corporation is a global enterprise dedicated to the development, manufacturing, sales, and servicing of an extensive range of solutions, categorized into imaging, healthcare, materials, and business innovation. Its Healthcare division provides a comprehensive suite of products and services designed for prevention, diagnosis, and treatment. These offerings include medical devices, biomedical contract development and manufacturing organization (CDMO) services, pharmaceuticals, regenerative medicine, and cosmetics and dietary supplements. The Materials segment focuses on industrial applications, supplying inkjet digital presses and printing plates for the printing sector, along with industrial inkjet products and print heads. It also offers data storage media and archiving solutions for digital information management, as well as advanced materials for displays, touch panels, semiconductors, image sensors, and functional films. Within the Business Innovation segment, the company delivers office-oriented devices and services, such as digital multifunction machines, printers, software, and cloud-based solutions. It further provides workflow optimization tools for graphical communications companies and offers tailored document services, including system integration and business process outsourcing, to meet diverse business requirements. The Imaging segment covers both traditional photography and advanced optical technologies. It features products like color films, instant cameras, photo developing and printing systems, color papers, and photo printing services. Additionally, this segment produces high-quality optics, including lenses for TV and cinema production, surveillance cameras, industrial inspection, and projectors. Founded in 1934, FUJIFILM Holdings Corporation is headquartered in Tokyo, Japan.

SectorHealthcare
IndustryMedical - Devices
CountryJapan
Trades inJPY

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Unlock all fundamental data for this stock

Unlimited access to every company

See plans

Unlock all fundamental data for this stock

Unlimited access to every company

See plans